Resources

SPotlight Newsletter


Spotlight Newsletter

Summer Issue 2018

President's Report

“Summertime is always the best of what might be” as Charles Bowden once said. I am confident that the quote holds true for all of us.

We have multiple initiatives underway as we reach the half-way point in 2018 and as we approach our Annual Meeting in Washington DC. I strongly encourage you to take a moment today to register for our 2018 Annual Meeting as well as for our social evening event on October 2 at an attractive venue close to the White House. Please do not forget to book your hotel as well!

In addition to the Annual Meeting, we are preparing for three regional meetings in 2018. Please save the dates of September 6 (Brussels) and November 14 (Boston and Bay Area, CA). Details for the meetings are being finalized and more information will be shared in the coming month. Registration for all SPS Regional Meetings will open this summer and information will be posted online and announced via email. I would like to thank the volunteers who are working on the respective organizing committees.

Another meeting I would like to highlight is the Drug Safety Africa 2018 meeting which will be held in South Africa in November. SPS is supporting the meeting with member expertise and we encourage your participation. I am sure attendance will be an unforgettable experience.

Jean-Pierre Valentin (SPS Past President) and Derek Leishman (SPS Past President) as well as other SPS members recently participated in the CIPA update meeting in May, which was organized in Washington DC. Those discussions will certainly influence some of the content at the SPS Annual Meeting. If you are interested in learning more, the presentation slides can be downloaded here.

As you may know our 3-year strategic plan expires at the end of 2018. The 2016-2018 Strategic Plan was nicely summarized in a recent publication in the Journal of Pharmacological and Toxicological Methods (JPTM) and we encourage you to read it. One of the tasks the Board of Directors is charged with this Summer and Fall is to create a new strategic plan which leads the way into the future. For that purpose, we have begun the research stage of strategic planning by starting with a member’s survey. The results of the survey will influence the shape and direction we take as a Society, so please help by completing the survey by July 1. We appreciate your time in this activity, many thanks! We will use this data to prepare for our Face to Face meeting in Washington, DC where we will work with a strategic planning facilitator to help us accomplish the creation of an innovative and new strategic plan in time for release by the end of the year.

Meanwhile, I hope you are enjoying our webinars, and remember if you missed any of the live webinars, you may view them anytime by visiting the Webinars page under the section called “past webinars” (member login required).

In closing, I would like to personally thank the members of the Society who have so graciously agreed to take an active role on a committee or other Society activity. I am truly amazed that our members are so willing to commit their time and energies to further the Society. The shared goals and strong sense of community among our broad membership is perhaps one of the greatest strengths of our Society.

See you in Washington, DC!

Martin Traebert, PhD, DSP, ERT
President, Safety Pharmacology Society


Annual Meeting News

Top Reasons to Attend the 2018 SPS Annual Meeting

On behalf of the Safety Pharmacology Society (SPS) Board of Directors and Officers, we would like to invite you to attend the 2018 SPS Annual Meeting at the Marriott Wardman Park Hotel in the historic, international city of Washington, DC. The 2018 SPS Annual Meeting provides a dynamic forum for sharing the latest in safety pharmacology.





Top Reasons to Attend the Meeting

  • A dynamic forum for best practice sharing within industry, CRO’s, academics, clinicians and regulators
  • Sessions on some of the hottest topics in safety pharmacology related research
  • 6 Continuing Education Courses taught by experts in the field
  • 2 Plenary Keynote Presentations by key opinion leaders
  • Exhibit hall offering access to 50+ industry vendors
  • 180+ Poster submissions featuring cutting-edge research
  • Networking opportunities with a global community of scientists from regulatory, industry, and academia
  • Award opportunities to bring together Student and Jr. Investigators with seasoned scientists
  • Sponsored Sessions by leading technology and service providers showcasing new technologies and research

The 2018 Scientific Program features a diverse range of scientific sessions organized into two themed tracks and covering issues such as:

  • Secondary Pharmacology: From the Test Tube to the Clinic
  • Next Generation Non-opiate Pain Management
  • Safety Pharmacology/FDA Discussion on the Gastrointestinal System
  • CiPA Real-life Implementation
  • Cardio-Oncology
  • Central Nervous System and Sensory Assessments: Established and Emerging Nonclinical Drug Safety Testing Strategies
  • Advanced Imaging Techniques in Preclinical Safety
  • In Silico Approaches
  • From Bench to Bedside—Translational Clinical Pharmacology Designs
  • Preclinical to Clinical—Case Studies

The meeting also offers a broad Continuing Education program both on an introductory level as well as advanced courses for the expert. A program outline is now available on the 2018 Meeting website. For those interested in increasing their knowledge, recognition and expertise in the field, we will also be holding the 2018 certification exam for the Diplomate in Safety Pharmacology on September 29 and invite all interested SPS members to consider sitting the exam this year.

Join us in Washington, DC for our 2018 Annual Meeting this Fall!

Register by July 15 and Save $200!

Register Online | Mail or Fax Registration Form


2018 Annual Meeting Mobile App: Coming Soon!

The 2018 SPS Annual Meeting mobile app is coming soon!

This interactive app will allow you to:

  • View the schedule and sessions, save sessions to your personal agenda, and get detailed presenter information.
  • Stay up to date on the most popular sessions, promotions, and events in the Activity Feed.
  • Receive announcements and obtain the most up-to-date information about what's going on.
  • Expand your professional network and have fun by interacting with other attendees in the app.

Visit our website for more information and download instructions!
The Mobile App is scheduled to launch one month prior to the Meeting.


2018 Abstract Deadline Extended to June 22

Great news! We have extended the Abstract submission deadline by one week. If you have already submitted your abstract, please feel free to log in and make edits to your submission between now and then. If you have not yet submitted, please be sure to finalize your abstract and submit it by June 22. The Jr. Investigator and Student Travel Award application deadline (July 1) has not been extended.


Student and Academic Opportunities

Travel Awards for Students and Junior Investigators

To encourage and support world-wide representation of students and junior investigators at the Meeting, SPS offers Junior Investigator Travel Awards and Student Travel Awards. The deadline for submitting award applications is July 1, 2018.

The deadline to submit your abstract online for the award is June 22, 2018. All other award application materials are due by July 1, 2018. Please visit our website for complete details on Travel Award eligibility.

Support for Educational Training/Workshops

SPS offers funding opportunities for undergraduate and graduate students to participate in educational training, workshops, meetings, and mentorships to help further their knowledge and career. The goal of this funding is to enable undergraduate and graduate students to engage in additional education and career development opportunities to enhance their personal development. Please visit our website for eligibility information.


Hotel Deadlines—Book Today!

2018 SPS Annual Meeting Housing Reservation Deadline—September 4

The Washington Marriott Wardman Park is the headquarters hotel. We have negotiated a room block with the hotel at the group rate of $239 exclusive of taxes.

The headquarters hotel is located in the Northwest DC’s Woodley Park neighborhood, a quiet oasis in the heart of the city with 16 acres of gardens, just steps away from the Metro, Adams Morgan and Dupont Circle. The SPS Annual Meeting will take place in the Washington Marriott Wardman Park.

Washington Marriott Wardman Park
2660 Woodley Road NW
Washington, DC 20008
USA

To make reservations, please use the online reservation system, or call +1 202.328.2000 and identify yourself as part of the SPS group rate.


Waived Registration: US Federal and International Regulatory Agency Employees

In order to facilitate greater interaction with our regulatory colleagues, all US federal employees, and international regulatory agency employees may register to attend the 2018 SPS Annual Meeting at no charge. Waived registration is available to all active US federal employees, and all active employees at international regulatory agencies (must show valid regulatory/government ID at registration).

Registration is required by September 1.


Partner with Us! 2018 Sponsorship Opportunities

SPS is in the process of planning our 2018 Annual Meeting to be held September 30–October 3, 2018 in Washington, DC. The meeting attracts over 500 participants from around the globe. Over the last few months, the Program Committee has been hard at work to organize a scientific program that is inclusive of topics across the broad range of interests to our members and colleagues in the field.

General Annual Meeting Support

It is through the generous support of companies like yours that SPS has been able to offer affordable educational programs, such as our Annual Meeting, to a global audience. We hope that you will consider supporting the Society by becoming a sponsor of the 2018 Annual Meeting. Please refer to the 2018 Sponsorship Levels showing the detailed list of benefits/recognition that SPS can offer in return for your support. If a formal grant/support request needs to be submitted online, we would be happy to complete the next steps to ensure we comply with your company's policy.

Become a Sponsor

2018 SPS Evening Event Sponsorship (W Hotel)

In addition to the Annual Meeting support, we have two Diamond Level ($6,000) sponsorship opportunities available for our special event on October 2 at the W Hotel Washington, DC. This event provides a unique and fun experience for attendees to participant in an evening social event with colleagues. These two opportunities provide a fun way for your company to interact with attendees by sponsoring the bar for the evening, or the photobooth station. Details on the special event opportunities are available upon request.


Exhibit Opportunities at the 2018 Annual Meeting

Networking + Science at the premier event in the industry.

500 + high-level, influential decision makers
Industry professionals looking to Exhibitors for innovative, emerging technology solutions
Four days of intensive best practice sharing, networking and education

As an Exhibitor, you receive:

  • Two complimentary full conference registrations, which allow exhibitors to participate in all scientific sessions and social functions;
  • Company listing and exhibit location published in the Society's Annual Meeting Program provided to all meeting attendees;
  • All networking functions including breaks, lunches, and poster sessions within the exhibit space;
  • A variety of ways to communicate and connect with attendees through exclusive advertising and marketing opportunities.

Don't wait, there are only THREE booths left! Join us today to become part of this extraordinary program!

Reserve your booth today!


Advertising & Marketing Opportunities

ANNUAL MEETING MARKETING & ADVERTISING

We have a large variety of advertising and marketing opportunities available to companies who wish to have a presence at the 2018 Annual Meeting and beyond. These opportunities include items such as; email blasts to attendees, mobile app push notifications, mailing list rentals, sponsored education opportunities, unique visual advertising in the meeting space, and final program advertising.

Please note: some opportunities are exclusive to exhibitors and sponsors, and many are limited opportunities.

Please read through our Advertising and Marketing Prospectus to view all the opportunities available. Availability for each opportunity is updated on the advertising and marketing page.

Please email Amy Willis to secure your opportunity!


SPS NEWS

2018 Diplomate in Safety Pharmacology (DSP) Certification Exam and Preparation

The Diplomate in Safety Pharmacology (DSP) has gained increasing recognition over the last five years. With more than sixty Diplomates as of today, the certification includes members representing all major areas of our discipline including academia, industry and regulatory agencies. Achieving global recognition, the DSP establishes high quality standards for professionals evolving in the field of safety pharmacology. The Safety Pharmacology Society invites you to register to participate in our Diplomate in Safety Pharmacology (DSP) certification exam this fall in Washington, DC on September 29, 2018.

All details relative to the certification exam process including eligibility, study materials, scientific scope, and examination format are presented on the DSP website.

Register for the DSP Exam today!


2018 Distinguished Service Award Recipient

The Safety Pharmacology Society is honored to recognize its 2018 Distinguished Service Award Recipient, Mary Jeanne Kallman, PhD, DSP.

The award is in recognition of Dr. Kallman's significant scientific contributions to many areas of safety pharmacology including neuro-safety pharmacology and regulatory guidance. Dr. Kallman’s body of work over the past 30 years has been impressive.

Please be sure to attend Dr. Kallman’s DSA presentation at the 2018 SPS Annual Meeting on Wednesday, October 3, 2018 at 09:15.


2018 SPS Regional Meetings: Save the Date

September 6, 2018
Brussels, Belgium

SPS European Regional Meeting: Safety Pharmacology Meets Toxicology

The Safety Pharmacology Society European regional meeting, Safety Pharmacology Meets Toxicology, will be held at the UCB BioPharma site in Braine-l’Alleud, Belgium on September 6th, 2018, immediately after Eurotox that will take place in Brussels, one step away from UCB BioPharma.

Toxicologists, do not miss this chance to interact with the safety pharmacology community and deepen your knowledge of this discipline; Safety pharmacologists, do not miss this unique opportunity for open discussion with toxicologists and to network with your colleagues!

Amongst others, presentations will cover the integration of safety pharmacology parameters in toxicology studies, including case examples. The concept of adversity (i.e. NOAEL) related to safety pharmacology parameters will then be addressed with a panel discussion on this topic to close the day.

November 14, 2018
Boston, MA

SPS Boston (East Coast) Regional Meeting: Advanced Gene Technology in Gene Therapy — Role of Safety Pharmacology?*

Details for the SPS Boston Regional Meeting are being finalized and more information will be shared in the coming months.

November 14, 2018
Bay Area, CA

SPS Bay Area California Regional Meeting: Translational Safety Pharmacology*

Details for the SPS Bay Area California Regional Meeting are being finalized and more information will be shared in the coming months.

*Titles are tentative and subject to change

Registration for all SPS Regional Meetings will open this summer, information will be posted online and will be announced via email.

We hope to see you at a future SPS Regional Meeting!


NC3Rs Primate Welfare Meeting: London, November 15

Submit your abstract for this years Primate Welfare Meeting by Friday July 27. This is a unique, international event for sharing best practice in the use and care of non-human primates (NHPs).

Typically, this meeting covers the latest developments in NHP husbandry and training, the refinement of scientific procedures, advances in welfare assessment and other topics, with plenty of opportunities for networking with colleagues in NHP research, breeding and management.


NC3Rs FOB survey: Invitation to contribute by June 29

The FOB/Irwin tests are standard methods for investigating safety signals during the development of pharmaceuticals. However, there is little information on how the tests are carried out and how the data generated is used to inform decision making. In collaboration with an international Expert Working Group, the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) is conducting a survey to gather information on how the tests and data are used.

We would like to receive responses from those who generate, work with or make decisions based on data from the FOB/Irwin tests in any species, as stand-alone studies or integrated within other (e.g. toxicology) studies. We welcome responses from those working in drug development, those working for contract research organisations (CROs) and those working in ancillary roles, such as consultants.

We ask that you provide honest accounts of your experience and opinion on the FOB/Irwin tests, as your input will be used as the basis of a publication to examine the state-of-the-art in CNS safety assessment. Information is requested on rodents (mice and rats) and large animals (dogs, minipigs and non-human primates). All data collected in this survey will be treated in strict confidence and held securely by the NC3Rs. For queries about or problems with the survey, please contact sam.jackson@nc3rs.org.uk.

To participate or to get more information on this important survey of the CNS safety pharmacology community, please click the link below. The survey will close on June 29.

https://www.surveymonkey.co.uk/r/T9ZDB9B


Drug Safety Africa 2019: Invitation to Attend



ABOUT THE EVENT

New drugs are beginning to make inroads against some of the most important and debilitating diseases threatening mankind. The need is still great in western countries, in which ageing populations face the onset of diseases of the central nervous system (e.g. Alzheimer’s disease, Parkinson’s disease and psychiatric diseases), the cardiovascular system (arterial disease with associated stroke and myocardial infarction) and cancer. Africa is further challenged with the still high incidence of HIV and related autoimmune diseases as well as carrier-mediated infectious diseases such as malaria. The hallmark of any new, successful medicine is the clinical proof of efficacy and proof of its safety with clinical use. Thus, drug safety and tolerability is a prerequisite for dealing with the current medical needs of the world, including those of Africa. Most of this work has not been conducted in Africa but times are changing, and new infrastructure is being put into place to fill this void. It is time to bring drug safety into Africa for the benefit of the population. For the first time, an international conference will be held to bring together African experts with others across the world to discuss current approaches and challenges to drug safety testing.

Three main areas of drug safety will be addressed in this conference: safety pharmacology, toxicology and clinical drug safety. Each day will include two plenary lectures by international experts. The plenary lecturers will be asked to address newly developed methods and approaches to enhance the prediction of drug safety with their ultimate use in a diverse patient population. Of particular interest and a dedicated focus point for the plenary lectures will be the degree of translation between both in vitro and in vivo preclinical studies first to first-in-man clinical trials and to further, larger clinical trials. Within the preclinical area, the use of novel experimental approaches to better predict the clinical performance of new drugs will be a main theme. Which new models appear to offer the potential for enhancing the predictability of adverse events with clinical use of a new drug? Where should new investments be made to further improve on the current situation both from the preclinical as well as clinical perspective. This will have an impact on the data required in future for the demonstration of drug safety. The conference will provide a forum for regulators for new developments in drug safety testing.

WHO SHOULD ATTEND

Any individual in the academic or business environment with an interest in drug safety as a subject will benefit from this conference, specifically: Academia; Medicine and drug compound developers; Clinical and preclinical trial project managers; Regulatory agencies; Medical and pharmaceutical researchers; Geneticists and molecular biologists involved in drug development and therapeutic models; Heads of drug safety; Quality control & assurance managers; Compliance and regulatory affairs managers; Drug safety practitioners; Public health officers.

For more information and to register, please visit the website at www.drugsafetyafrica.com


SPS Collaborations and Activities

2018
SOT Scientific Liaison Coalition (Member since 2011)
JSPS Meeting Participation (February 2018)
SLC Webinar (February 2018)
DGPT/SPS German Pharm-Tox Summit course support/participation (February 2018)
SOT Global Gallery participant (March 2018)
UW Madison Distance Learning Course support (April-May 2018)


Upcoming Webinars

Upcoming Meetings


MEMBER NEWS

AnaBios Announces the Hire of Dr. Chris Mathes as Chief Commercial Officer

We wish to congratulate SPS member, Chris Mathes, on his recent hire as chief commercial officer at AnaBios in San Diego, CA. VIEW THE FULL PRESS RELEASE

Recent Publications of Interest

Action Potential Recording and Pro-arrhythmia Risk Analysis in Human Ventricular Trabeculae

Safety pharmacology in and for Africa: Establishment of the pre-clinical drug development platform

Pharmacological validation of individual animal locomotion, temperature and behavioural analysis in group-housed rats using a novel automated home cage analysis system: A comparison with the modified Irwin test